.FDA denies experimental MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Accept MDMA Therapy, Seeking Even More Study The New York City TimesFDA Denies Ecstasy-Based Drug The Stock market JournalFDA rejects to approve unique MDMA treatment to handle post-traumatic stress disorder, with request for more hearing information CNNFDA declines first experimental to address PTSD, calling for more research The Washington Post.